|
|
|
Volumn 20, Issue 1 SUPPL., 2014, Pages
|
|
Attainment of diabetes-related quality measures with canagliflozin versus sitagliptin
a a a a a a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
CALCIUM CHANNEL BLOCKING AGENT;
CANAGLIFLOZIN;
DIURETIC AGENT;
GLYCOSYLATED HEMOGLOBIN;
HEMOGLOBIN A1C;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
LOW DENSITY LIPOPROTEIN CHOLESTEROL;
METFORMIN;
RENIN INHIBITOR;
SITAGLIPTIN;
SULFONYLUREA;
ANTIDIABETIC AGENT;
GLUCOSIDE;
PYRAZINE DERIVATIVE;
SODIUM GLUCOSE COTRANSPORTER 2;
THIOPHENE DERIVATIVE;
TRIAZOLE DERIVATIVE;
ANTIHYPERTENSIVE THERAPY;
ARTICLE;
BLOOD PRESSURE;
BLOOD PRESSURE MEASUREMENT;
BLOOD SAMPLING;
BODY MASS;
BODY WEIGHT;
CHOLESTEROL BLOOD LEVEL;
CLINICAL ASSESSMENT;
CLINICAL EVALUATION;
CONTROLLED STUDY;
DIABETIC PATIENT;
DIURETIC THERAPY;
DOUBLE BLIND PROCEDURE;
DRUG EFFICACY;
DRUG SAFETY;
FEMALE;
GLYCEMIC CONTROL;
HEALTH CARE QUALITY;
HEMOGLOBIN BLOOD LEVEL;
HUMAN;
HYPERGLYCEMIA;
HYPERTENSION;
MAJOR CLINICAL STUDY;
MALE;
NON INSULIN DEPENDENT DIABETES MELLITUS;
PHASE 3 CLINICAL TRIAL;
POST HOC ANALYSIS;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
TREATMENT DURATION;
WEIGHT REDUCTION;
AGED;
ANCESTRY GROUP;
ANTAGONISTS AND INHIBITORS;
BLOOD;
CLINICAL TRIAL;
DIABETES MELLITUS, TYPE 2;
DRUG COMBINATION;
MIDDLE AGED;
AGED;
BLOOD PRESSURE;
BODY MASS INDEX;
CHOLESTEROL, LDL;
CONTINENTAL POPULATION GROUPS;
DIABETES MELLITUS, TYPE 2;
DOUBLE-BLIND METHOD;
DRUG THERAPY, COMBINATION;
FEMALE;
GLUCOSIDES;
HEMOGLOBIN A, GLYCOSYLATED;
HUMANS;
HYPOGLYCEMIC AGENTS;
MALE;
METFORMIN;
MIDDLE AGED;
PYRAZINES;
QUALITY INDICATORS, HEALTH CARE;
SODIUM-GLUCOSE TRANSPORTER 2;
THIOPHENES;
TRIAZOLES;
|
|
EID: 84905664996
PISSN: 10880224
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (15)
|
|
References (0)
|